Streptococcus pneumoniae serotype 3 genotypes in invasive isolates from Colombia

Introduction: Streptococcus pneumoniae serotype 3 is an important cause of pneumonia, bacteremia, and meningitis.Objective: To establish the circulating genotypes of S. pneumoniae serotype 3 isolates recovered from the invasive disease between 1994 to 2015 in Colombia.Materials and methods: Of the 365 S. pneumoniae serotype 3 isolates recovered through the laboratory national surveillance program, 117 isolates were analyzed. Pulsed-field gel electrophoresis was used for genotyping, and multilocus sequence typing was determined in representative isolates.Results: The frequency of this serotype increased from 2.7% between 1994 and 1998 to 9.1% between 2011 and 2015 (p=0.000); 91.7% of the isolates showed a genetic similarity greater than 77% and were related to the Netherlands³-31(PMEN31) clone CC180. Several subtypes were identified, two of which showed antimicrobial resistance.Conclusion: In Colombia, the pneumococcal population of the capsular type 3 shows a continuous and homogeneous circulation relating to the clonal group ST-180.     

应用差异蛋白质组学的方法分析左氧氟沙星对肺炎链球菌D39的作用

应用差异蛋白质组学的方法,对肺炎链球菌D39在左氧氟沙星作用下蛋白质表达水平的变化进行了研究,利用质谱技术共鉴定到23个差异蛋白质。这些蛋白质主要参与DNA的复制、转录以及蛋白质的翻译过程,为深入了解抗生素的作用机理以及细菌的耐药机制提供重要理论基础。     

肺炎链球菌18C血清型荚膜多糖黏度的初步探讨

目的初步探讨18C型肺炎链球菌(简称肺炎球菌)荚膜多糖的黏度性质及不同溶液体系对其黏度的影响,为肺炎球菌多糖蛋白结合疫苗工艺开发和优化提供基础资料。方法采用黏度计测定不同相对分子质量、不同温度、不同浓度水溶液、不同盐浓度溶液体系和不同pH条件下18C型多糖溶液的黏度。结果 18C型多糖溶液黏度与多糖相对分子质量呈正相关,与溶液温度呈线性负相关(R~2>0.99),与多糖浓度呈线性正相关(R~2>0.98);在0.15 mol/L NaCl溶液中其黏度最小,随盐浓度的增加,其黏度呈线性增加(R~2>0.98);溶液体系pH接近多糖等电点时,溶液的黏度较低,高于其等电点,溶液黏度增加,随后pH变化对溶液黏度的影响不明显。结论以18C型多糖为例,报道了肺炎球菌荚膜多糖溶液黏度及其在不同条件下的变化,提示在这一领域需要进一步的系统研究,为指导疫苗工艺开发、优化提供依据。     

A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection

Streptococcus suis serotype 2 is a major Gram-positive swine pathogen, causing also zoonoses. We describe here the immunoprotective activity in an in vivo animal model of a serotype-2 cell wall protein, designated Sat, which was identified by a previously validated proteomics approach consisting of the protease digestion of live bacteria and the selective recovery of exposed domains, followed by LC/MS/MS analysis. Increased survival rate (80%) and decreased bacterial burden were observed in mice immunized with a recombinant Sat fragment, suggesting that this protein is a potential vaccine candidate against serotype-2 infection.     

Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide

Human C-reactive protein (CRP) protects mice from lethality after infection with virulent Streptococcus pneumoniae type 3. For CRP-mediated protection, the complement system is required; however, the role of complement activation by CRP in the protection is not defined. Based on the in vitro properties of CRP, it has been assumed that protection of mice begins with the binding of CRP to pneumococcal C-polysaccharide on S. pneumoniae and subsequent activation of the mouse complement system. In this study, we explored the mechanism of CRP-mediated protection by utilizing two CRP mutants, F66A and F66A/E81A. Both mutants, unlike wild-type CRP, do not bind live virulent S. pneumoniae. We found that passively administered mutant CRP protected mice from infection as effectively as the wild-type CRP did. Infected mice injected with wild-type CRP or with mutant CRP lived longer and had lower mortality than mice that did not receive CRP. Extended survival was caused by the persistence of reduced bacteremia in mice treated with any CRP. We conclude that the CRP-mediated decrease in bacteremia and the resulting protection of mice are independent of an interaction between CRP and the pathogen and therefore are independent of the ability of CRP to activate mouse complement. It has been shown previously that the Fcgamma receptors also do not contribute to such CRP-mediated protection. Combined data lead to the speculation that CRP acts on the effector cells of the immune system to enhance cell-mediated cytotoxicity and suggest investigation into the possibility of using CRP-loaded APC-based strategy to treat microbial infections.     

Characterization of mutants deficient in the L,D-carboxypeptidase (DacB) and WalRK (VicRK) regulon, involved in peptidoglycan maturation of Streptococcus pneumoniae serotype 2 strain D39

Peptidoglycan (PG) hydrolases play critical roles in the remodeling of bacterial cell walls during division. PG hydrolases have been studied extensively in several bacillus species, such as Escherichia coli and Bacillus subtilis, but remain relatively uncharacterized in ovococcus species, such as Streptococcus pneumoniae (pneumococcus). In this work, we identified genes that encode proteins with putative PG hydrolytic domains in the genome of S. pneumoniae strain D39. Knockout mutations in these genes were constructed, and the resulting mutants were characterized in comparison with the parent strain for growth, cell morphology, PG peptide incorporation, and in some cases, PG peptide composition. In addition, we characterized deletion mutations in nonessential genes of unknown function in the WalRK(Spn) two-component system regulon, which also contains the essential pcsB cell division gene. Several mutants did not show overt phenotypes, which is perhaps indicative of redundancy. In contrast, two new mutants showed distinct defects in PG biosynthesis. One mutation was in a gene designated dacB (spd_0549), which we showed encodes an L,D-carboxypeptidase involved in PG maturation. Notably, dacB mutants, similar to dacA (D,D-carboxypeptidase) mutants, exhibited defects in cell shape and septation, consistent with the idea that the availability of PG peptide precursors is important for proper PG biosynthesis. Epistasis analysis indicated that DacA functions before DacB in D-Ala removal, and immunofluorescence microscopy showed that DacA and DacB are located over the entire surface of pneumococcal cells. The other mutation was in WalRK(Spn) regulon gene spd_0703, which encodes a putative membrane protein that may function as a type of conserved streptococcal shape, elongation, division, and sporulation (SEDS) protein.     

Dihydroavenanthramide D protects pancreatic β-cells from cytokine and streptozotocin toxicity

Dihydroavenanthramide D (DHAvD) is a synthetic analog to naturally occurring avenanthramide, which is the active component of oat. Although its anti-inflammatory, antiatherosclerotic, and antioxidant effects have been reported, the effect of DHAvD on type 1 diabetes is unknown. Therefore, in this study, the effect of DHAvD on cytokine- or streptozotocin-induced β-cell damage was investigated. Treatment of RINm5F insulinoma cells or isolated islets with IL-1β and IFN-γ induced β-cell damage through a NF-κB-dependent signaling pathway. DHAvD-pretreated RINm5F cells or islets showed resistance to cytokine toxicity, namely suppressed nitric oxide (NO) production, reduced the inducible form of NO synthase expression, and decreased β-cell destruction and the normal insulin secretion capacity. Furthermore, pretreatment with DHAvD blocked the development of type 1 diabetes in streptozotocin-treated mice. Prior injection with DHAvD maintained a normal range of plasma glucose and insulin, and retained immunoreactivity for insulin in the pancreas. These results suggest that DHAvD may be used to preserve functional β-cell mass.     

The teichoic acid (C-polysaccharide) synthesized by Streptococcus pneumoniae serotype 5 has a specific structure

The teichoic acid synthesized by Streptococcus pneumoniae serotype 5, also known as pneumococcal common antigen (C-polysaccharide), was purified. On the basis of compositional analysis, HPAEC-PAD analysis, MALDI-TOF mass spectrometry and NMR spectroscopy, made on the native polysaccharide and on the dephosphorylated repeating unit, the following structure is proposed: [structure: see text]. This C-polysaccharide (C-PS), differs from those previously described by the replacement of Glc by Gal in its repeating unit structure.     

Metallothionein 2A induction by zinc protects HEPG2 cells against CYP2E1-dependent toxicity

Zinc has been shown to have antioxidant actions, which may be due, in part, to induction of metallothionein (MT). Such induction can protect tissues against various forms of oxidative injury because MT can function as an antioxidant. The objective of this study was to investigate if zinc or MT induction by zinc could afford protection against CYP2E1-dependent toxicity. HepG2 cells overexpressing CYP2E1 (E47cells) were treated with 60 microM arachidonic acid (AA), which is known to be toxic to these cells by a mechanism dependent on CYP2E1, oxidative stress, and lipid peroxidation. E47 cells were preincubated overnight in the absence or presence of metals such as zinc or cadmium that can induce MT. The culture medium containing the metals was removed, AA was added, and cell viability determined after 24 h incubation. Preincubation overnight with 150 microM zinc sulfate or 5 microM cadmium chloride induced a 20- to 30-fold increase of MT2A mRNA; high levels of MT2A mRNA were maintained during the subsequent challenge period with AA, even after the zinc was removed. MT protein levels were increased about 4- to 5-fold during the overnight preincubation with zinc and a 20- to 30-fold increase was observed 24 h after zinc removal during the AA challenge. The treatment with zinc was associated with significant protection against the loss of cell viability caused by AA in E47 cells. The zinc pretreatment protected about 50% against the DNA fragmentation, cell necrosis, the enhanced lipid peroxidation and increased generation of reactive oxygen species, and the loss of mitochondrial membrane potential induced by AA treatment in E47 cells. CYP2E1 catalytic activity and components of the cell antioxidant defense system such as glutathione (GSH), glutathione-S-transferase (GST), glutathione peroxidase (GPX), catalase, Cu,Zn superoxide dismutase (SOD), and MnSOD were not altered under these conditions. Zinc preincubation also protected the E47 cells against BSO-dependent toxicity. When E47 cells were coincubated with zinc plus AA for 24 h (i.e., zinc was not removed, nor was there a preincubation period prior to challenge with AA), AA toxicity was increased. Thus, zinc had a direct pro-oxidant effect in this model and an indirect antioxidant effect, perhaps via induction of MT. MT may have potential clinical utility for the prevention or improvement of liver injury produced by agents known to be metabolized by CYP2E1 to reactive intermediates and to cause oxidative stress.     

高致病性2型猪链球菌毒素-抗毒素系统SezAT

<正>高致病性2型猪链球菌(Streptococcus suis serotype 2,SS2)属于革兰氏阳性B组链球菌,是一种重要的人畜共患传染病病原菌,它不仅可以导致猪出现急性败血症、脑膜炎、关节炎、心内膜炎及急性死亡,还可以通过伤口和呼吸道等传播途径,导致人的感染。自1998及2005年我国发生两次2型猪链球菌大流行后,该菌所引起的链球菌毒素休克综合征引起国际高度重视,我国不少学者聚焦该领域的研究[1]。本刊2012年第2期刊登了王敏、胡福泉等的文章"高致病性2型猪链球菌毒-抗素毒素系统SezAT的鉴     

肺炎链球菌pcsB组成型表达的yycF缺陷菌株的构建及其致病能力

【背景】YycFG双组分系统是肺炎链球菌(Streptococcus pneumoniae,S. pn)应对外界环境的重要信息传递系统,其中表达反应调节子YycF的编码基因是肺炎链球菌生长的必需基因,但其是否调控细菌毒力尚不清楚。【目的】构建肺炎链球菌pcsB组成型表达及yycF缺陷菌,分析YycF对肺炎链球菌生物学特征和毒力的影响。【方法】采用Janus cassette (JC)反选的方法构建pcsB组成型表达菌株(Pc-PcsB~+),从该菌株出发用替代失活的方法构建yycF缺陷菌株(Pc-PcsB~+DyycF),比较野生株D39rpsl41、pcsB组成型表达株及yycF缺陷株的生长特性、荚膜多糖(capsular polysaccharide,CPS)含量、粘附侵袭能力和致病性的差异。【结果】成功构建pcsB组成型表达的yycF缺陷菌株(Pc-PcsB+DyycF);yycF缺陷导致细菌生长缓慢、分裂异常、胞内荚膜多糖和小分子荚膜多糖增多;体外实验结果显示,yycF缺陷菌株粘附能力较Pc-PcsB~+菌株减弱(P=0.006)。体内毒力实验显示,感染野生菌的小鼠全部死亡,感染Pc-PcsB+和Pc-PcsB~+DyycF菌株的小鼠死亡率分别为91.7%、75%,二者没有统计学差异(P=0.183),但Pc-PcsB~+DyycF菌株感染组有降低趋势;定殖结果显示,yycF缺陷菌株感染组的肺匀浆菌载量显著低于对照组(P=0.033)。【结论】成功构建yycF缺陷菌株,并初步证明yycF基因会影响肺炎链球菌的生物性状和致病能力,为后续探讨YycFG双组分系统对肺炎链球菌致病能力调控机制的研究奠定了基础。